{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:59:40Z","timestamp":1790967580929,"version":"4.1.0"},"reference-count":60,"publisher":"Public Library of Science (PLoS)","issue":"2","license":[{"start":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T00:00:00Z","timestamp":1329868800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0032168","type":"journal-article","created":{"date-parts":[[2012,2,22]],"date-time":"2012-02-22T22:13:04Z","timestamp":1329948784000},"page":"e32168","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":21,"title":["Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-\u039ab Activation"],"prefix":"10.1371","volume":"7","author":[{"given":"Emilie","family":"Zuercher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Butticaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josiane","family":"Wyniger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Battegay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Boffi El Amari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanh","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Fran\u00e7ois","family":"Egger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Fehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Mueller-Garamv\u00f6gyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Parini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan C.","family":"Schaefer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franziska","family":"Schoeni-Affolter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Thurnheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Tinguely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Rothenberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"and the Swiss HIV cohort study","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2012,2,22]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/nrc1452","article-title":"Epstein-Barr virus: 40 years on.","volume":"4","author":"LS Young","year":"2004","journal-title":"Nat Rev Cancer"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/emboj\/17.6.1700","article-title":"Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.","volume":"17","author":"E Kilger","year":"1998","journal-title":"Embo J"},{"key":"ref3","first-page":"2982","article-title":"Latent membrane protein 1 is critical for efficient growth transformation of human B cells by epstein-barr virus.","volume":"63","author":"U Dirmeier","year":"2003","journal-title":"Cancer Res"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"9150","DOI":"10.1073\/pnas.90.19.9150","article-title":"Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation.","volume":"90","author":"KM Kaye","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/0092-8674(85)90256-9","article-title":"An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells.","volume":"43","author":"D Wang","year":"1985","journal-title":"Cell"},{"key":"ref6","first-page":"461","article-title":"Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus.","volume":"2","author":"VR Baichwal","year":"1988","journal-title":"Oncogene"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/344777a0","article-title":"Epstein-Barr virus latent membrane protein inhibits human epithelial cell differentiation.","volume":"344","author":"CW Dawson","year":"1990","journal-title":"Nature"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/JVI.66.11.6496-6501.1992","article-title":"Epstein-Barr virus latent membrane protein transactivates the human immunodeficiency virus type 1 long terminal repeat through induction of NF-kappa B activity.","volume":"66","author":"ML Hammarskjold","year":"1992","journal-title":"J Virol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1128\/JVI.69.5.2968-2976.1995","article-title":"Stimulation of NF-kappa B-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus.","volume":"69","author":"T Mitchell","year":"1995","journal-title":"J Virol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"6055","DOI":"10.1073\/pnas.100119497","article-title":"NF-kappa B inhibition causes spontaneous apoptosis in Epstein-Barr virus-transformed lymphoblastoid cells.","volume":"97","author":"ED Cahir-McFarland","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.0105-2896.2006.00375.x","article-title":"Circuitry of nuclear factor kappaB signaling.","volume":"210","author":"A Hoffmann","year":"2006","journal-title":"Immunol Rev"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/sj.cdd.4401838","article-title":"Good cop, bad cop: the different faces of NF-kappaB.","volume":"13","author":"ND Perkins","year":"2006","journal-title":"Cell Death Differ"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1182\/blood-2005-07-2730","article-title":"NF-kappaB is essential for the progression of KSHV- and EBV-infected lymphomas in vivo.","volume":"107","author":"SA Keller","year":"2006","journal-title":"Blood"},{"issue":"Pt 10","key":"ref14","first-page":"2399","article-title":"Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma.","volume":"72","author":"LF Hu","year":"1991","journal-title":"J Gen Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/viro.2001.0828","article-title":"The transmembrane domains of the EBV-encoded latent membrane protein 1 (LMP1) variant CAO regulate enhanced signalling activity.","volume":"282","author":"SM Blake","year":"2001","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1128\/JVI.72.5.4038-4048.1998","article-title":"The 30-base-pair deletion in Chinese variants of the Epstein-Barr virus LMP1 gene is not the major effector of functional differences between variant LMP1 genes in human lymphocytes.","volume":"72","author":"RJ Johnson","year":"1998","journal-title":"J Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1182\/blood-2008-09-180315","article-title":"HIV-associated lymphomas and gamma-herpesviruses.","volume":"113","author":"A Carbone","year":"2009","journal-title":"Blood"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"e96","DOI":"10.1371\/journal.pmed.0040096","article-title":"HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts.","volume":"4","author":"O Gasser","year":"2007","journal-title":"PLoS medicine"},{"key":"ref19","article-title":"Hodgkin&apos;s Disease in Patients with HIV Infection.","author":"M Spina","year":"2011","journal-title":"Adv Hematol 2011"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/S0959-8049(01)00105-8","article-title":"Pathogenetic and histogenetic features of HIV-associated Hodgkin&apos;s disease.","volume":"37","author":"R Dolcetti","year":"2001","journal-title":"Eur J Cancer"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1182\/blood-2009-02-204172","article-title":"Hodgkin lymphoma in the Swiss HIV Cohort Study.","volume":"113","author":"GM Clifford","year":"2009","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.","volume":"97","author":"GM Clifford","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.1038\/sj.onc.1206556","article-title":"Epstein-Barr virus and oncogenesis: from latent genes to tumours.","volume":"22","author":"LS Young","year":"2003","journal-title":"Oncogene"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1128\/JVI.51.2.411-419.1984","article-title":"Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein.","volume":"51","author":"S Fennewald","year":"1984","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00018-002-8413-y","article-title":"Association of the Epstein-Barr virus latent membrane protein 1 with lipid rafts is mediated through its N-terminal region.","volume":"59","author":"S Rothenberger","year":"2002","journal-title":"Cell Mol Life Sci"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1099\/0022-1317-36-1-59","article-title":"Characteristics of a human cell line transformed by DNA from human adenovirus type 5.","volume":"36","author":"FL Graham","year":"1977","journal-title":"J Gen Virol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jviromet.2003.10.015","article-title":"Detection of wild type and deleted latent membrane protein 1 (LMP1) of Epstein-Barr virus in clinical biopsy material.","volume":"116","author":"J Nicholls","year":"2004","journal-title":"J Virol Methods"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/BF01973638","article-title":"Epstein-Barr virus infection in HIV-positive patients.","volume":"12","author":"A Telenti","year":"1993","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.78.2.868-881.2004","article-title":"Potential selection of LMP1 variants in nasopharyngeal carcinoma.","volume":"78","author":"RH Edwards","year":"2004","journal-title":"J Virol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1182\/blood.V89.5.1723.1723_1723_1731","article-title":"Epstein-Barr virus strains with latent membrane protein-1 deletions: prevalence in the Italian population and high association with human immunodeficiency virus-related Hodgkin&apos;s disease.","volume":"89","author":"R Dolcetti","year":"1997","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1182\/blood.V82.10.2937.2937","article-title":"Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin&apos;s disease and identical to those observed in nasopharyngeal carcinoma.","volume":"82","author":"H Knecht","year":"1993","journal-title":"Blood"},{"key":"ref32","first-page":"523","article-title":"Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders.","volume":"10","author":"H Knecht","year":"1995","journal-title":"Oncogene"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.virusres.2009.07.005","article-title":"The extent of genetic diversity of Epstein-Barr virus and its geographic and disease patterns: a need for reappraisal.","volume":"143","author":"CM Chang","year":"2009","journal-title":"Virus research"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/viro.1999.9855","article-title":"Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains.","volume":"261","author":"RH Edwards","year":"1999","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1086\/314672","article-title":"The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene.","volume":"179","author":"DM Walling","year":"1999","journal-title":"J Infect Dis"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1182\/blood.V90.1.323","article-title":"Sequence analysis of the Epstein-Barr virus (EBV) latent membrane protein-1 gene and promoter region: identification of four variants among wild-type EBV isolates.","volume":"90","author":"K Sandvej","year":"1997","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"9129","DOI":"10.1128\/JVI.75.19.9129-9141.2001","article-title":"Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways.","volume":"75","author":"CA Fielding","year":"2001","journal-title":"J Virol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1128\/JVI.00135-06","article-title":"LMP1 strain variants: biological and molecular properties.","volume":"80","author":"BA Mainou","year":"2006","journal-title":"J Virol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1038\/sj.onc.1201696","article-title":"The NPC derived C15 LMP1 protein confers enhanced activation of NF-kappa B and induction of the EGFR in epithelial cells.","volume":"16","author":"WE Miller","year":"1998","journal-title":"Oncogene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s11262-008-0262-9","article-title":"Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1.","volume":"37","author":"D Nguyen-Van","year":"2008","journal-title":"Virus Genes"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1590\/S0100-879X2008000200006","article-title":"Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes.","volume":"41","author":"YL Tang","year":"2008","journal-title":"Braz J Med Biol Res"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11262-006-0008-5","article-title":"Sequence variations of Epstein-Barr virus LMP1 gene in nasal NK\/T-cell lymphoma.","volume":"34","author":"M Nagamine","year":"2007","journal-title":"Virus Genes"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/(SICI)1097-0215(19980504)76:3<399::AID-IJC18>3.0.CO;2-6","article-title":"Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong.","volume":"76","author":"ST Cheung","year":"1998","journal-title":"Int J Cancer"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s11262-004-5630-5","article-title":"Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas.","volume":"30","author":"KY Jen","year":"2005","journal-title":"Virus Genes"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"4084","DOI":"10.1128\/JVI.64.9.4084-4092.1990","article-title":"Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B, and EBNA-3C genes.","volume":"64","author":"J Sample","year":"1990","journal-title":"J Virol"},{"key":"ref46","first-page":"1575","article-title":"Clonability and tumorigenicity of human epithelial cells expressing the EBV encoded membrane protein LMP1.","volume":"8","author":"LF Hu","year":"1993","journal-title":"Oncogene"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin lymphoma and immunodeficiency in persons with HIV\/AIDS.","volume":"108","author":"RJ Biggar","year":"2006","journal-title":"Blood"},{"key":"ref48","first-page":"99","article-title":"Epstein-Barr virus-encoded latent membrane protein-1 expression as prognostic factor in AIDS-related non-Hodgkin&apos;s lymphoma.","volume":"9","author":"U Tirelli","year":"1995","journal-title":"AIDS"},{"key":"ref49","first-page":"2319","article-title":"Human immunodeficiency virus-associated Hodgkin&apos;s disease derives from post-germinal center B cells.","volume":"93","author":"A Carbone","year":"1999","journal-title":"Blood"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.humpath.2007.05.020","article-title":"Epstein-Barr virus-associated lymphoproliferative disorders.","volume":"38","author":"SA Rezk","year":"2007","journal-title":"Human pathology"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"4108","DOI":"10.1128\/JVI.78.8.4108-4119.2004","article-title":"Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.","volume":"78","author":"ED Cahir-McFarland","year":"2004","journal-title":"Journal of virology"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1073\/pnas.94.4.1447","article-title":"The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.","volume":"94","author":"KM Izumi","year":"1997","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"ref53","first-page":"1845","article-title":"Nuclear factor-kappaB activation is involved in LMP1-mediated transformation and tumorigenesis of rat-1 fibroblasts.","volume":"60","author":"Z He","year":"2000","journal-title":"Cancer research"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/nrd2781","article-title":"Is NF-kappaB a good target for cancer therapy? Hopes and pitfalls.","volume":"8","author":"V Baud","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"ref55","first-page":"491","article-title":"Molecular biology of Hodgkin lymphoma.","author":"R Kuppers","year":"2009","journal-title":"Hematology\/the Education Program of the American Society of Hematology American Society of Hematology Education Program"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pathol.4.110807.092209","article-title":"Pathogenesis of classical and lymphocyte-predominant Hodgkin lymphoma.","volume":"4","author":"R Schmitz","year":"2009","journal-title":"Annual review of pathology"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2559.2010.03705.x","article-title":"The molecular pathogenesis of Hodgkin lymphoma.","volume":"58","author":"K Farrell","year":"2011","journal-title":"Histopathology"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/jmv.20782","article-title":"Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients.","volume":"79","author":"RM Correa","year":"2007","journal-title":"J Med Virol"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1099\/0022-1317-82-5-1169","article-title":"Demonstration by single-cell PCR that Reed\u2013Sternberg cells and bystander B lymphocytes are infected by different Epstein\u2013Barr virus strains in Hodgkin&apos;s disease.","volume":"82","author":"N Faumont","year":"2001","journal-title":"The Journal of general virology"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1093\/ije\/dyp321","article-title":"Cohort profile: the Swiss HIV Cohort study.","volume":"39","author":"F Schoeni-Affolter","year":"2010","journal-title":"International journal of epidemiology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0032168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T22:25:18Z","timestamp":1593728718000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0032168"}},"subtitle":[],"editor":[{"given":"Kwok-Wai","family":"Lo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":60,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2012,2,22]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0032168","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}